Maclean and Jansen Advocate for Open-Source Modeling in Pharmaceutical Executive
Precision’s Ross Maclean and Jeroen Jansen encourage biopharma and medical device industries to embrace the developments around value assessment and to take a leading role in improving the transparency of cost-effectiveness evaluations. (more…)
Schafer and Hennessey on the Importance of Value Among Pharma Marketers
In a feature in Pharma Live, Precision’s Jeremy Schafer and Maureen Hennessy predict that the projected growth in healthcare spend is creating an inevitable marketplace shift from volume to value. (more…)
Shafrin Quoted on the Use of Real-World Evidence
Precision’s Jason Shafrin comments in PMLive on the importance of real-world evidence and the benefits of electronic medical records in generating evidence. (more…)
Precision’s Kohler, Quigley, Guennel on Meeting FDA Specialty Lab Data Requirements
With increased biomarker and specialty lab data being incorporated into FDA submissions, drug developers are running into challenges as they prepare data that comply with new regulatory requirements. (more…)